Enliven Therapeutics, Inc.
- Stock
- Ticker ELVN
- Nasdaq
Performance, volatility and drawdowns of Enliven Therapeutics, Inc. since 03/2020, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $32,313. Global equities (VT): $14,653.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −98.2% in 04/2022, measured from the peak in 06/2020. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Operating income | -27 | -32 | -29 | -25 | -34 | -28 | -37 | -36 |
| EBITDA | -27 | -32 | -29 | -25 | -34 | -28 | -37 | -36 |
| Net income | -23 | -29 | -25 | -20 | -30 | -24 | -32 | -28 |
| Earnings per share | -0.46 | -0.57 | -0.49 | -0.32 | -0.48 | -0.38 | -0.49 | -0.36 |
| Balance sheet | ||||||||
| Total assets | 326 | 303 | 504 | 491 | 476 | 465 | 910 | 897 |
| Liabilities | 16 | 14 | 15 | 15 | 17 | 11 | 15 | 20 |
| Equity | 310 | 288 | 488 | 476 | 460 | 453 | 895 | 877 |
| Cash | 124 | 102 | 119 | 102 | 99 | 132 | 136 | 152 |
| Cash flow | ||||||||
| Operating cash flow | -17 | -24 | -17 | -13 | -16 | -19 | -19 | -13 |
| Capital expenditure | 0.0 | 0.0 | -0.1 | 0.0 | 0.0 | 0.0 | -0.1 | -0.1 |
| Free cash flow | -17 | -24 | -17 | -13 | -16 | -19 | -19 | -13 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2022 at +81.8%, weakest 2021 at −89.8%. 2 of 5 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 5 Nov 2026 | −$0.36 |
| 5 Aug 2026 | −$0.49 |
| 7 May 2026 | −$0.38 |
| 3 Mar 2026 | −$0.48 |
| 12 Nov 2025 | −$0.32 |
| 13 Aug 2025 | −$0.49 |
| 14 May 2025 | −$0.57 |
| 13 Mar 2025 | −$0.46 |
| 13 Nov 2024 | −$0.48 |
| 13 Aug 2024 | −$0.41 |
| 14 May 2024 | −$0.54 |
| 14 Mar 2024 | −$0.46 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €3.1bn
- Market cap in trading currency
- $3.42bn
- Enterprise value
- $2.54bn
- P/E
- –
- P/S
- –
- P/B
- 3.90
- EV/Sales
- –
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- -1.9%
Results (last four quarters)
- Revenue
- –
- Gross profit
- –
- EBITDA
- −$135m
- Net income
- −$113m
- Earnings per share
- −$1.71
- Revenue per share
- –
- Revenue growth
- –
- Earnings growth
- –
Profitability
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity
- -16.8%
- Return on assets
- -12.6%
Balance sheet and cash flow
- Cash
- $884m
- Cash per share
- $12.02
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 45.95
- Book value per share
- $11.92
- Operating cash flow
- −$66.2m
- Free cash flow
- −$66.4m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 73.6m
- Volume
- 933,555
- Avg. volume 3 months
- 1.36m
- Relative volume
- 0.7
Price and technicals
- Price
- $46.53
- 1 day
- +0.3%
- 52-week high
- $61.15
- 52-week low
- $15.14
- Distance to 52-week high
- −23.9%
- Distance to 52-week low
- +207.3%
- Distance to 50-day line
- +2.6%
- Distance to 200-day line
- +5.0%
- RSI (14)
- 50
- Volatility 1M
- 59.1%
Performance
- 1 week
- −4.7%
- 1 month
- +11.0%
- 3 months
- −23.9%
- 6 months
- +12.0%
- YTD
- +202.1%
- 1 year
- +110.5%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has ELVN performed since 03/2020?
$10,000 grew to $7,755 by 20 Nov 2026, which is −3.7% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is ELVN?
Volatility was 90.3% per year, measured on monthly returns. The largest decline from a peak was −98.2%, with the low in 04/2022.
How does ELVN compare with a broad equity ETF?
Over the same period Global equities (VT) returned +15.9% per year at 15.4% volatility, ELVN returned −3.7% at 90.3%. The correlation of monthly returns was 0.14; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.